Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of PCI+ACB vs IPACK+ACB vs ACB for Analgesia in TKA
NCT05943080Completed
- Sponsor
- Kırşehir Ahi Evran University
- Start
- Jun 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Kırşehir Ahi Evran University. Primary endpoints: Visual Analog Scale Pain Score at 72 hours and Total Opioid Consumption at 72 hours. Started Jun 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05943080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05943080.